At Arcella, we are redefining how biomedical intelligence and patient care come together. Our vision is to make advanced AI and data analytics accessible to everyone in healthcare, from researchers and clinicians to patients navigating their own cancer journey. By transforming complex scientific information into actionable insights, we bridge the gap between discovery, clinical decision-making, and real-world outcomes. Our main mission is to develop a CE-certified, medical-grade application that redefines how colorectal cancer is managed. This interactive, AI-powered Oncology Companion supports patients from diagnosis through treatment, recovery, and long-term health management - providing personalised guidance, symptom and lifestyle tracking, and emotional support. It improves patients' quality of life while generating de-identified real-world evidence that fuels precision medicine and the development of future therapies.
| Website | https://arcella.bio/ |
| Employees | 2 (1 on RocketReach) |
| Founded | 2023 |
| Industry | Biotechnology Research |
| Competitors | Cannabis Science Inc., MJBiz Hemp+CBD, Zenabis Global Inc., Canopy Growth Corporation, Cronos Group, Tilray Brands, Inc., Hexo, Aphria, Cresco Labs, Trulieve +35 more (view full list) |
Looking for a particular Arcella Bio employee's phone or email?
Pavels Kartasevs is the Founder of Arcella Bio.
1 people are employed at Arcella Bio.